background
develop
vaccin
prevent
sever
acut
respiratori
syndrom
sar
limit
lack
wellcharacter
anim
model
previou
vaccin
report
note
robust
neutral
antibodi
inflammatori
respons
ferret
result
enhanc
hepat
method
evalu
humor
immun
respons
patholog
end
point
ferret
challeng
urbani
strain
sarsassoci
coronaviru
sarscov
receiv
formalininactiv
wholeviru
vaccin
mock
vaccin
result
humor
respons
observ
ferret
receiv
inactiv
viru
vaccin
histopatholog
find
lung
show
infect
ferret
produc
residu
lung
lesion
seen
mock
vaccin
ferret
sarscov
infect
demonstr
bronchial
bronchiolar
hyperplasia
perivascular
cuf
ferret
lung
tissu
seen
previous
infect
mice
evid
enhanc
diseas
observ
ferret
ferret
clear
viru
day
week
earlier
vaccin
conclus
vaccin
provid
mild
immun
protect
ferret
challeng
howev
evid
enhanc
liver
lung
diseas
induc
inactiv
wholeviru
vaccin
ferret
may
provid
anoth
use
model
evalu
sar
vaccin
safeti
efficaci
sever
acut
respiratori
syndrom
sar
associ
coronaviru
sarscov
emerg
infecti
pathogen
zoonot
origin
sarscov
found
certain
bat
popul
china
outbreak
occur
china
late
viru
appar
amplifi
intermediari
host
chines
wet
market
pandem
last
juli
peopl
infect
worldwid
death
countri
sinc
end
sar
pandem
sever
infect
observ
direct
transmiss
bat
human
observ
date
sar
potenti
reappear
anim
reservoir
accident
intent
releas
develop
effect
vaccin
anim
model
highli
desir
prevent
contain
futur
outbreak
sarscov
attenu
kill
sarscov
dna
viralvector
vaccin
evalu
number
anim
model
includ
mous
ferret
hamster
nonhuman
primat
refer
within
howev
mani
anim
model
exhibit
respons
infect
similar
record
human
particular
immun
enhanc
report
felin
infecti
periton
fip
coronaviru
fipcov
vaccin
exacerb
hepat
report
sarscov
spike
protein
vaccin
express
vaccinia
vector
ferret
potenti
problem
aris
sarscov
vaccin
need
examin
ferret
mustela
putoriu
furo
first
note
note
lung
diseas
score
follow
lesion
minim
degre
lesion
mild
moder
fisar
formalininactiv
sever
acut
respiratori
syndromeassoci
coronaviru
vaccin
viru
collect
use
swab
dulbecco
modifi
eagl
medium
analyz
tcid
assay
limit
viral
detect
assay
log
tcid
ml
suscept
sarscov
infect
although
ferret
die
pneumonia
viru
isol
lung
tissu
neutral
monoclon
antibodi
administ
ferret
prophylact
complet
prevent
sarscovinduc
macroscop
lung
diseas
significantli
reduc
viral
shed
pharyng
secret
immun
ferret
modifi
recombin
vaccinia
viru
vaccin
induc
neutral
antibodi
also
induc
strong
inflammatori
respons
possibl
lead
enhanc
hepat
respons
link
recombin
vaccinia
viru
express
sarscov
protein
ferret
chosen
model
test
vaccin
safeti
report
link
enhanc
liver
diseas
vaccin
ferret
wellcharacter
model
studi
respiratori
virus
success
infect
sarscov
although
studi
lack
microhistopatholog
data
lung
tissu
also
unclear
past
report
coronavirus
anim
previous
expos
use
coronavirusfre
anim
examin
effect
inactiv
vaccin
viru
challeng
addit
analysi
humor
respons
examin
lung
tissu
ferret
microhistopatholog
analysi
result
pilot
studi
provid
basi
futur
experi
ferret
model
demonstr
inactiv
vaccin
show
evid
enhanc
diseas
result
obtain
ferret
model
good
compar
mous
model
addit
anim
system
use
evalu
sar
vaccin
safeti
efficaci
african
green
monkey
kidney
vero
cell
use
grow
sarscov
urbani
strain
dulbecco
modifi
eagl
medium
dmem
biosourc
supplement
fetal
bovin
serum
mmoll
lglutamin
uml
penicillin
mgml
streptomycin
mgml
fungizon
biosourc
intern
supernat
collect
pool
clarifi
centrifug
store
use
viral
stock
stock
filter
millexg
figur
neutral
antibodi
titer
ferret
vaccin
formalininactiv
sever
acut
respiratori
syndrom
sar
associ
coronaviru
vaccin
fisar
b
challeng
mockvaccin
ferret
challeng
c
data
express
dilut
serum
prevent
cytopath
effect
well
calcul
method
reed
muench
result
individu
ferret
shown
note
scale
chang
challeng
mm
filter
unit
millipor
titer
tcid
ml
determin
tcid
assay
describ
elsewher
ferret
ten
coronavirusfre
femal
ferret
harlan
hous
individu
week
observ
vaccin
ferret
hous
biosafeti
level
bsl
laboratori
viru
challeng
laboratori
light
manag
delay
estru
ferret
come
estru
given
dose
human
chorion
gonadotropin
iu
ferret
monitor
daili
care
health
ferret
lightli
anesthet
ketamin
mg
kg
xylazin
mgkg
acepromazin
mgkg
intramuscularli
well
atropin
mgkg
collect
blood
sampl
jugular
vein
challeng
sarscov
ferret
monitor
awaken
thereaft
check
ensur
eat
drink
behav
normal
euthanasia
perform
pentobarbitol
sodium
mgml
kg
bodi
weight
initi
sedat
ketaminexylazineacepromazin
per
guidelin
institut
anim
care
use
committe
center
biolog
evalu
research
us
food
drug
administr
accord
guidelin
nation
institut
health
anim
care
use
committe
nasal
pharyng
swab
nasal
swab
obtain
premoisten
dmem
swab
nostril
ferret
small
sampl
collect
millimet
nose
laryngoscop
use
view
glotti
pharyng
swab
collect
use
dacrontip
applic
gener
vaccin
ml
viru
stock
tcid
ml
treat
ml
formalin
h
inactiv
viru
ml
dialyz
l
pb
room
temperatur
h
medium
uninfect
vero
cell
treat
way
prepar
mock
vaccin
vaccin
plate
vero
cell
day
confirm
inactiv
vaccin
done
intramuscularli
ml
per
leg
without
adjuv
five
ferret
given
sar
vaccin
given
mock
vaccin
tabl
immun
repeat
boost
week
viru
challeng
tcid
ml
split
part
ml
given
intratrach
ml
given
intranas
laryngoscop
use
intratrach
portion
deliv
via
syring
plastic
angiocathet
attach
intranas
inoculum
deliv
nostril
via
plastic
bulbtyp
pipettor
four
ferret
vaccin
group
challeng
live
sarscov
day
boost
tabl
quantit
viral
titer
viral
titer
determin
observ
infect
vero
monolay
plate
use
tcid
assay
tenfold
serial
dilut
viral
sampl
incub
day
examin
cytopath
effect
cpe
infect
cell
describ
elsewher
briefli
cpe
sarscovinfect
vero
cell
determin
observ
round
detach
cell
close
associ
first
dilut
viral
sampl
dilut
set
limit
viral
detect
assay
log
tcid
ml
microneutr
assay
ferret
serum
treat
min
inactiv
complement
dilut
dmem
serial
dilut
serum
made
tissu
cultur
plate
ad
ml
serum
dilut
equal
volum
dmem
carri
dilut
describ
elsewher
equal
volum
sarscov
tcid
ad
mixtur
incub
h
room
temperatur
mixtur
plate
onto
vero
cell
cultur
detect
presenc
nonneutr
viru
dilut
serum
prevent
cpe
cell
cultur
well
report
antibodi
neutral
titer
elisa
immuno
maxisorp
plate
nunc
coat
ml
per
well
mgml
recombin
sarscov
spike
protein
imgenex
mmoll
sodium
carbon
coat
buffer
imgenex
overnight
antigen
remov
plate
block
ml
per
well
bovin
serum
albumin
bsa
trisbuff
salin
tween
tbst
h
room
temperatur
ferret
serum
dilut
tbst
bsa
ad
duplic
well
incub
room
temperatur
plate
wash
tbst
peroxidaseconjug
goat
antiferret
igg
kirkegaard
perri
laboratori
goat
antiferret
igg
igaigm
rockland
use
detect
bound
antibodi
peroxidas
substrat
solut
kpl
contain
use
develop
plate
nm
model
micropl
reader
biorad
laboratori
histopatholog
analysi
ferret
euthan
day
challeng
liver
lung
major
organ
fix
formalin
embed
paraffin
section
stain
hematoxylineosin
select
liver
lesion
stain
steiner
techniqu
ferret
health
evalu
digit
thermomet
use
take
ferret
rectal
temperatur
ferret
weigh
weekli
ferret
blood
chemistri
analysi
perform
serum
drawn
day
challeng
weekli
thereaft
use
vet
scan
ii
analyz
abaxi
liverprofil
rotor
ferret
inocul
mock
vaccin
formalininactiv
wholeviru
sarscov
vaccin
week
booster
immun
administ
week
later
test
ferret
challeng
intratrach
intranas
live
sarscov
nasal
pharyng
swab
collect
day
challeng
weekli
thereaft
incub
cell
cultur
titrat
analys
figur
two
day
challeng
viral
titer
similar
pharynx
nose
sarscov
vaccin
figur
mock
vaccin
figur
group
day
challeng
ferret
sarscov
vaccin
group
clear
viru
pharynx
figur
ferret
mock
vaccin
group
clear
viru
day
figur
earlier
clear
viru
pharyng
secret
indic
inactiv
sarscov
vaccin
provid
immun
protect
ferret
examin
level
immun
respons
provid
inactiv
sarscov
vaccin
use
serum
perform
neutral
assay
two
ferret
receiv
sarscov
vaccin
display
neutral
antibodi
second
immun
taper
week
figur
sarsvaccin
ferret
show
littl
neutral
antibodi
even
second
immun
ferret
display
high
level
neutral
antibodi
week
challeng
titer
wane
week
infect
concurr
clearanc
viru
figur
mockvaccin
ferret
show
viru
neutral
challeng
data
shown
increas
neutral
week
challeng
lower
titer
sarsvaccin
ferret
figur
mockvaccin
ferret
show
high
neutral
titer
week
infect
also
high
viru
titer
day
one
mockvaccin
ferret
clear
viru
tabl
alp
alkalin
phosphatas
alt
alanin
aminotransferas
nd
done
day
figur
high
neutral
antibodi
titer
figur
develop
neutral
antibodi
strongli
induc
vaccin
significantli
induc
challeng
ferret
suggest
vaccin
immunolog
robust
character
humor
immun
respons
vaccin
evalu
potenc
humor
immun
respons
elicit
sarscov
vaccin
infect
measur
virusspecif
igg
level
ferret
serum
elisa
overal
signific
elev
spikespecif
igg
level
seen
result
vaccin
day
viru
challeng
induc
mark
elev
level
igg
antibodi
figur
mockvaccin
nonchalleng
ferret
display
antibodi
sarscov
spike
protein
data
shown
sarsvaccin
ferret
produc
higher
level
spikespecif
igg
challeng
antibodi
detect
week
earlier
mockvaccin
ferret
suggest
prime
effect
vaccin
determin
whether
observ
due
gener
igm
antibodi
iggigaigm
measur
level
antibodi
also
slightli
elev
sarsvaccin
ferret
detect
earlier
mockvaccin
ferret
figur
suggest
although
vaccin
gener
weak
antigen
respons
spike
protein
may
prime
immun
respons
lead
higher
level
antibodi
figur
faster
clear
viru
patholog
find
lung
tissu
vaccin
ferret
four
mockvaccin
sarsvaccin
ferret
challeng
sarscov
two
ferret
use
uninfect
control
anim
ferret
euthan
day
challeng
mockvaccin
unchalleng
control
ferret
bronchiolar
epithelium
appear
normal
thick
inflamm
bronchial
bronchiolar
hyperplasia
observ
figur
mockvaccin
sarscovinfect
ferret
focal
bronchiolar
hyperplasia
figur
also
present
challeng
mockvaccin
sarsvaccin
ferret
figur
inflammatori
cell
mainli
lymphocyt
peribronchiolar
figur
addit
perivascular
cuf
around
small
blood
vessel
viru
found
lung
tissu
cultur
vitro
stain
section
data
shown
bronchial
bronchiolar
hyperplasia
evid
ferret
challeng
viru
evid
unchalleng
control
ferret
tabl
suggest
sarscov
infect
led
lesion
vaccin
lymphocyt
cuf
also
found
challeng
ferret
suggest
role
immun
system
resolv
pulmonari
infect
tabl
hepat
patholog
ferret
liver
appear
normal
gross
examin
histolog
major
liver
appear
normal
except
foci
necrosi
inflamm
ferret
expos
viru
uninfect
nonvaccin
control
ferret
lesion
foci
livercel
necrosi
mononuclear
infiltr
observ
figur
howev
phenomenon
alway
specif
featur
viral
hepat
evid
typic
viral
hepat
diffus
hepat
inflammatori
lesion
acidophil
bodi
piecem
necrosi
portal
tract
seen
observ
larger
lesion
sarsvaccin
ferret
figur
mockvaccin
ferret
figur
viru
found
liver
lesion
found
histolog
probabl
previou
viral
damag
check
presenc
bacteria
use
steiner
stain
hepat
lesion
found
none
ferret
health
blood
chemistri
elev
level
alanin
aminotransferas
alt
indic
hepat
observ
human
patient
sar
vaccin
ferret
use
blood
chemistri
analysi
evalu
ferret
health
vaccin
viru
infect
observ
elev
alkalin
phosphatas
level
mockvaccin
ferret
slightli
elev
alt
level
ferret
week
challeng
tabl
normal
rang
observ
thereaft
sarsvaccin
group
ferret
slightli
elev
alt
level
day
challeng
highli
elev
alt
level
week
later
tabl
level
return
normal
rang
consist
kinet
sarscov
infect
brief
oppos
result
immun
respons
expect
protract
liver
injuri
therefor
may
associ
weak
formalininactiv
wholeviru
vaccin
sarscov
infect
small
percentag
anim
ferret
bodi
weight
temperatur
ferret
sever
lung
lesion
also
largest
overal
weight
loss
figur
three
ferret
mock
vaccin
group
show
weight
loss
mean
loss
vaccin
nearli
full
recoveri
bodi
weight
clearanc
viru
day
except
ferret
lost
bodi
weight
viral
clearanc
figur
two
sarsvaccin
ferret
lost
weight
vaccin
recov
almost
normal
weight
vaccin
boost
figur
overal
sarsvaccin
ferret
maintain
gain
weight
challeng
suggest
overal
health
vaccin
ferret
better
one
ferret
vaccin
group
figur
spike
temperatur
day
boost
challeng
suggest
bodi
temperatur
associ
stress
signific
increas
bodi
temperatur
observ
ferret
vaccin
viru
challeng
figur
prepar
potenti
sarscov
outbreak
safe
effect
vaccin
must
avail
patholog
zoonot
viral
infect
indic
pneumocyt
primari
target
infect
result
diffus
alveolar
damag
evalu
safeti
efficaci
potenti
sarscov
vaccin
anim
model
need
reliabl
induc
sever
diseas
death
date
anim
model
mimic
human
sarscov
fatal
rate
lack
fact
anim
infect
sarscov
shown
sever
viral
pneumonia
lead
death
seen
human
infect
anim
infect
usual
character
bronchiolar
lesion
littl
alveolar
involv
ferret
long
use
studi
influenza
viru
infect
pathogenesi
ferret
plausibl
model
studi
sarscov
infect
pathogenesi
one
studi
nearli
human
patient
infect
sarscov
elev
alt
level
addit
sever
hepat
shown
predict
poor
clinic
outcom
patient
sar
one
report
demonstr
ferret
present
mild
focal
necrot
inflammatori
liver
lesion
result
sarscov
infect
enhanc
liver
diseas
highli
elev
alt
level
also
observ
ferret
vaccin
recombin
vaccinia
viru
vaccin
express
sarscov
spike
protein
evalu
humor
immun
respons
sarscov
immun
infect
observ
high
alt
level
ferret
vaccin
inactiv
sarscov
live
viru
challeng
differ
may
due
sever
factor
specif
viral
strain
use
titer
viru
challeng
strength
immun
respons
specif
respons
spike
protein
use
femal
ferret
presenc
absenc
vaccinia
viru
compon
experi
need
settl
appar
differ
studi
lung
lesion
mild
minim
sever
focal
lung
histolog
normal
none
lesion
would
probabl
caus
ill
death
bronchiol
perivascular
lesion
seem
relat
previou
viru
exposur
similar
lesion
found
monkey
mice
day
week
exposur
lesion
found
ferret
lung
diffus
worst
lesion
lung
ferret
mock
vaccin
group
consist
virusassoci
vaccineassoci
diseas
lesion
found
ferret
includ
bronchiolar
hyperplasia
perivascular
cuf
often
found
monkey
mice
experiment
sarscov
infect
lesion
usual
reportedfoc
hepat
inflamm
minim
recov
viru
lung
liver
tissu
ferret
euthan
optim
time
viru
collect
use
ferret
evalu
safeti
weak
inactiv
wholeviru
vaccin
antibodydepend
enhanc
ade
observ
fipcov
infect
may
part
pathogenesi
sarscov
infect
diseas
associ
sarscov
infect
result
immunemedi
infiltr
airway
lymphocyt
macrophag
enhanc
diseas
mark
increas
viral
titer
prior
exposur
viru
viru
compon
case
fip
viru
gain
entri
macrophag
cell
via
neutral
antibodi
spike
envelop
protein
bind
viru
intern
cell
macrophag
shown
viral
infect
patient
sar
concern
macrophag
provid
addit
host
substrat
viru
may
grow
furthermor
earli
robust
seroconvers
associ
sever
diseas
patient
sar
implic
sar
immunemedi
diseas
sarscov
gain
entri
macrophag
antibodi
vaccin
elicit
respons
may
safe
purpos
design
weak
vaccin
elicit
mild
antibodi
respons
test
possibl
low
antibodi
titer
associ
enhanc
pulmonari
diseas
oppos
strong
antibodi
respons
complet
protect
see
increas
viral
titer
vaccin
ferret
versu
mockvaccin
ferret
vaccin
induc
ade
suggest
condit
inactiv
wholeviru
vaccin
provid
measur
protect
without
risk
enhanc
lung
liver
diseas
still
need
kinet
studi
show
infect
ferret
protect
infect
dosedepend
manner
furthermor
role
play
level
immun
respons
ade
need
analyz
sever
anim
model
shown
promis
use
evalu
sar
antivir
vaccin
safeti
efficaci
notabl
studi
use
mice
hamster
although
eas
use
larg
number
small
rodent
make
mous
hamster
model
invalu
difficulti
perform
experi
contain
condit
limit
use
larger
anim
ferret
may
provid
conveni
altern
nonhuman
primat
addit
model
small
rodent
show
weak
formalininactiv
vaccin
enhanc
diseas
ferret
good
model
evalu
sar
vaccin
safeti
efficaci
